期刊文献+

重组人肿瘤坏死因子相关凋亡诱导配体的药代动力学和组织分布 被引量:1

Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-related apoptosis-inducing ligand
下载PDF
导出
摘要 目的研究重组人肿瘤坏死因子相关凋亡诱导配体(rhTRAIL)的药代动力学和组织分布。方法恒河猴单次静脉滴注rhTRAIL1,5和25mg.kg-1及iv5mg·kg-1后,采用酶联免疫吸附法(ELISA)测定rhTRAIL在恒河猴体内的血药浓度,并采用放射性核素示踪技术结合三氯乙酸(TCA)沉淀和分子排阻高效液相色谱法测定[125I]rhTRAIL在荷瘤裸鼠组织内的含量。结果恒河猴单次静脉滴注rhTRAIL1,5和25mg·kg-1后,各剂量组的药代参数除cmax和AUC以外,均无显著差异,表现出线性动力学性质。恒河猴每天给药1次,连续7d,药物在体内没有蓄积。恒河猴静脉滴注和iv给药对药物的体内清除过程无明显影响。[125I]标记rhTRAIL后的放化纯度大于98%。荷瘤裸鼠iv给予[125I]rhTRAIL后,在各组织广泛分布,总放射性在肿瘤组织中于给药后2h达到高峰,在其他大部分组织中于给药后10min达高峰。给药后10min及2,8和24h,肿瘤/血清的酸沉放射性比值分别为0.07±0.01,0.62±0.17,0.78±0.57和1.66±0.50;给药后24h,肿瘤组织的放射性浓度高于其他组织和血清。结论在研究剂量范围内,rhTRAIL在恒河猴体内表现为线性动力学。[125I]rhTRAIL给药后在荷瘤裸鼠中广泛分布,在肿瘤组织中分布浓度较高,并主要经肾脏排泄。 OBJECTIVE To investigate the pharmacokinetics and tissue distribution of recombinant human TNF-related apoptosis-inducing ligand (rhTRAIL). METHODS Macaca mulatta was given rhTRAIL 1, 5 and 25 mg·kg-1 by intravenous drip or iv 5 mg·kg-1, and enzyme-linked immunosorbent assay (ELISA) was used to investigate the pharmacokinetics of rhTRAIL. Radioisotopic tracing method combined with trichloroacetic acid (TCA) precipitation and high performance liquid chromatography method was used to determine tissue distribution of [125I]rhTRAIL in tumor-bearing nude mice. RESULTS After M.mulatta was given rhTRAIL 1, 5, and 25 mg·kg-1 by intravenous drip, there was no statistically significant difference between different groups in parameters except AUC and cmax. rhTRAIL complied with linear kinetics among 1-25 mg·kg-1. Besides, there was no accumulation tendency after M. mulatta was given rhTRAIL 5 mg·kg-1 once daily by intravenous drip for successive 7 d. As for the elimination process of rhTRAIL, there was no significant differences in pharmacokinetic parameters between iv administration and intravenous drip in M. mulatta. The purity of [125I]rhTRAIL was above 98%. [125I]rhTRAIL was distributed widely in the tissue of tumor-bearing nude mice after iv administration. Total radioactivity in the tumor reached the maximum at 2 h after administration while other tissues arrived at 10 min. At 10 min, 2, 8 and 24 h after administration, the TCA-precipitable radioactivity ratio of tumor to serum was 0.07±0.01, 0.63±0.17, 0.78±0.57, and 1.66±0.50, respectively. TCA-precipitable radioactivity of the tumor was higher than that of other tissues and serum at 24 h after administration. CONCLUSION rhTRAIL appears as linear kinetics among rhTRAIL 1-25 mg·kg-1 in M. mulatta. [125I]rhTRAIL is distributed widely in tissues of tumor-bearing nude mice after iv administration. [125I]rhTRAIL can reach a high concentration in the intended target tumor tissue and is eliminated primarily through the kidneys.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2010年第2期128-133,共6页 Chinese Journal of Pharmacology and Toxicology
关键词 TNF凋亡诱导配体 药代动力学 组织分布 TNF-related apoptosis-inducing ligand pharmacokinetics tissue distribution
  • 相关文献

参考文献3

二级参考文献17

  • 1Wiley SR,Schooley K.Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Im.munity,1995,3(6):673.
  • 2Walczak H,Miller RE,Ariail K,et al.Tumoricidal activity of tumor necrosis factor-related apoptosis—inducing ligand in vivo[J].Nat Med,1999,5(2):157.
  • 3Tanaka S,Sugimachi K,Shirabe K,et al.Expression and antitumof effects of trail in human cholangiocarcinoma[J].Hepatology, 2000.32(3):523.
  • 4Scan KK, Louise AH, David X, et al. Preclinieal studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics,and safety[J]. Pharmacol Exp Ther, 2001, 299 ( 1 ) : 31.
  • 5Clarke P,Menntzer SM,Gibson S,et al.Reovirus-induced apoptosis is mediated by TRAIL.J Virol,2000,74(17):8135-8139.
  • 6Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterizations of a new member of the TNF family that induces apoptosis.J Immunity,1995,3:673-682.
  • 7Schridan JP,Marsters SA,Pitti RM,et al.Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.Science,1997,277:818-821.
  • 8WILEY SR,SCHOOLEYK,SMOLAK PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995,3 (6):673-682.
  • 9PITTI RM,MARSTERS SA,RUPPERT S,et al.Induction of apoptosis by Apo-2 ligand,a new member of the tumor necrosis factor cytokine family[J].J Biol Chem,1996,271 (22):12687-12690.
  • 10BOURALEXIS S,FINDLAY DM,EVDOKIOU A.Death to the bad guys:Targeting cancer via Apo2L/TRAIL[J].Apoptosis,2005,10(1):35-51.

共引文献5

同被引文献6

  • 1WALCZAK H,MILLER RE,ARIAIL K,et al.Tumoricidal ac-tivity of tumor necrosis factor-related apoptosis-inducing ligand invivo[J].Nat Med,1999,5(2):157-163.
  • 2BUCHSBAUM D J,ZHOU T,LOBUGLIO AF.Trail receptor-tar-geted therapy[J].Future Oncol,2006,2(4):493-508.
  • 3XIANG H,NGUYEN CB,KELLEY SK,et al.Tissue distribu-tion,stability,and pharmacokinetics of Apo2 ligand/tumor necrosisfactor-related apoptosis-inducing ligand in human colon carcinomaCOLO205 tumor-bearing nude mice[J].Drug Metab Dispos,2004,32(11):1230-1238.
  • 4Jung C.G. Man and His Symbols. London: Aldus Books, 1964:3-4
  • 5Ritsema R. I Ching: The Classic Chinese Oracle of Change. London:Element Books, 1994:15
  • 6Jung. C. G. & Wilhelm, R. The Secret of the Golden Flower. New York: Causeway Books, 1975:90

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部